SanBio Co Ltd (SNBIF)
3.85
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
SanBio Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2023 | 3.315M |
| July 31, 2022 | 57.11M |
| July 31, 2021 | -2.734M |
| July 31, 2020 | -0.0377M |
| July 31, 2019 | 64.71M |
| Date | Value |
|---|---|
| July 31, 2018 | 104.09M |
| July 31, 2017 | 9.350M |
| July 31, 2016 | -3.368M |
| July 31, 2015 | 60.28M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.734M
Minimum
Jul 2021
64.71M
Maximum
Jul 2019
24.47M
Average
3.315M
Median
Jul 2023
Cash from Financing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -450.06M |
| Nxera Pharma Co Ltd | -12.29M |
| PeptiDream Inc | -5.103M |
| Healios KK | 14.90M |
| AnGes Inc | -- |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | -41.43% |